LNA (Locked Nucleic Acid): High-Affinity Targeting of Complementary RNA and DNA
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Locked nucleic acid (LNA) is a nucleic acid analogue containing one or more LNA nucleotide monomers with a bicyclic furanose unit locked in an RNA mimicking sugar conformation. LNA oligonucleotides display unprecedented hybridization affinity toward complementary single-stranded RNA and complementary single- or double-stranded DNA. Structural studies have shown that LNA oligonucleotides induce A-type (RNA-like) duplex conformations. The wide applicability of LNA oligonucleotides for gene silencing and their use for research and diagnostic purposes are documented in a number of recent reports, some of which are described herein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antisense oligonucleotides are an attractive therapeutic strategy because they can inhibit mRNA expression specifically [7, 8].”
From Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors (2014) · cites this paper as [8]
Citations
Cites
Asymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
Koshkin, A. A., Singh, S. K., Nielsen, P., Rajwanshi, V. K., Kumar, R., Meldgaard, M., Olsen, C. E., & Wengel, J. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00094-5 · Cited by 1,047
Self-citationAn autonomous molecular computer for logical control of gene expression
Benenson, Y., Gil, B., Ben-Dor, U., Adar, R., & Shapiro, E. (2004) · Nature · doi:10.1038/nature02551 · Cited by 821
LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition
Singh, S. K., Koshkin, A. A., Wengel, J., & Nielsen, P. (1998) · Chemical Communications · doi:10.1039/a708608c · Cited by 768
Self-citationObika, S., Nanbu, D., Hari, Y., Andoh, J.-I., Morio, K.-I., Doi, T., & Imanishi, T. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)01084-3 · Cited by 700
LNA: a versatile tool for therapeutics and genomics
Petersen, M., & Wengel, J. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(02)00038-0 · Cited by 613
Self-citationObika, S., Nanbu, D., Hari, Y., Morio, K.-I., In, Y., Ishida, T., & Imanishi, T. (1997) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)10322-7 · Cited by 610
Design of antisense oligonucleotides stabilized by locked nucleic acids
Kurreck, J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.1911 · Cited by 577
RNA Interference in Mammalian Cells by Chemically-Modified RNA
Braasch, D. A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M. A., & Corey, D. R. (2003) · Biochemistry · doi:10.1021/bi0343774 · Cited by 531
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
Wahlestedt, C., Salmi, P., Good, L., Kela, J., Johnsson, T., Hökfelt, T., Broberger, C., Porreca, F., Lai, J., Ren, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5633 · Cited by 520
Self-citation
Research works printed but not linked: 39
- Jepsen J. S., 2004, Curr. Opin. Drug Discovery Dev. 7, 188−194.
- Singh S. K., 1998, Chem. Commun. 4, 455−456.
- Koshkin A. A., 1998, Cytosine, Guanine, 5-Methylcytosine, Thymine and Uracil Bicyclonucleoside Monomers, Oligomerisation, and Unprecedented Nucleic Acid Recognition, Tetrahedron 54, 3607−3630.
- Wengel J., 1999, Acc. Chem. Res. 32, 301−310.
- McTigue P. M., 2004, Biochemistry 43, 5388−5405.
- Nielsen K. E., 2004, Bioconjugate Chem. 15, 449−457.
- Nielsen K. M. E., 2002, Chem.Eur. J., 8
- Nielsen J. T., 2003, Nucleic Acids Res. 31, 5858−5867.
- Wahlestedt C., 2000, Proc. Natl. Acad. Sci. U.S.A. 97
- Kurreck J., 2002, Nucleic Acids Res. 30
- Frieden M., 2003, Nucleic Acids Res. 31, 6365−6372.
- Crinelli R., 2002, Nucleic Acids Res. 30, 2435−2443.
- Santoro S. W., 1997, Proc. Natl. Acad. Sci. U.S.A. 94
- Schubert S., 2003, DNAzymes with enhanced stability and activity, Nucleic Acids Res. 31, 5982−5992.
- Fahmy R. G., 2004, Nucleic Acids Res. 32, 2281−2285.
- Obika S., 2001, Nucleic Acids Res. Suppl., 145−146.
- Hansen J. B., 2003, Nucleosides, Nucleotides Nucleic Acids 22, 1607−1609.
- Elayadi A. N., 2002, Biochemistry 41, 9973−9981.
- Childs J. L., 2002, Proc. Natl. Acad. Sci. U.S.A. 99
- Ittig D., 2004, Nucleic Acids Res. 32, 346−353.
- Grünweller A., 2003, Nucleic Acids Res. 31, 3185−3193.
- Braasch D. A., 2003, Biochemistry 42, 7967−7975.
- Schwarz D. S., 2003, Cell 115, 199−208.
- Arzumanov A., 2003, Oligonucleotides 13, 435−453.
- Buchini S., 2003, Curr. Opin. Chem. Biol. 7, 717−726.
- Obika S., 2000, Tetrahedron Lett., 41
- Obika S., 2001, Chem. 9, 1001−1011.
- Sun B. W., 2004, Biochemistry 43, 4160−4169.
- Goni J. R., 2004, Nucleic Acids Res. 32, 354−360.
- Hertoghs K. M., 2003, Nucleic Acids Res. 31, 5817−5830.
- Jacobsen N., 2002, Clin. Chem. 48, 657−660.
- Ørum H., 1999, Clin. Chem. 45
- Ugozzoli L. A., 2004, Anal. Biochem. 324, 143−152.
- Letertre C., 2003, Mol. Cell Probes 17, 307−311.
- Tolstrup N., 2003, Nucleic Acids Res. 31, 3758−3762.
- Silahtaroglu A. N., 2003, Mol. Cell Probes 17, 165−169.
- Sørensen M. D., 2003, Chem. Commun. 17, 2130−2131.
- Benenson Y., 2004, Nature 429, 423−429.
- Abbreviations LNA, locked nucleic acid
Cited by
Items 101–200 of 727
Kokil, G. R., Veedu, R. N., Ramm, G. A., Prins, J. B., & Parekh, H. S. (2015) · Chemical Reviews · doi:10.1021/cr5002832 · Cited by 108
Small non-coding RNA therapeutics for cardiovascular disease
Shah, A. M., & Giacca, M. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac463 · Cited by 100
“These locked nucleic acid (LNA) nucleotides confer remarkable thermal stability against enzymatic degradation while maintaining basepairing specificity.(10) However, for mRNA and larger ncRNA targeting, substrate duplexes with either LNA or 2′-O-alkylated RNA nucleotides are unable to recruit RNAse H and thus inhibiti…”
BackgroundSingle-Cell Sequencing Technologies: Current and Future
Liang, J., Cai, W., & Sun, Z. S. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.09.005 · Cited by 112
Superior structure stability and selectivity of hairpin nucleic acid probes with an L-DNA stem
Kim, Y., Yang, C. J., & Tan, W. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm771 · Cited by 97
Tsai, Y., Wang, H.-T. T., Chang, H. G., Tsai, C., Lin, C., Teng, P., Chen, S., Jeng, C., & Lee, P.-Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045278 · Cited by 96
“Strategies to enhance probe performance include conjugation of minor groove binding (MGB) group to its 39-end [25] and incorporation of locked nucleic acids (LNA) into the probe [26].”
BackgroundGene Silencing in Mammalian Cells with Light‐Activated Antisense Agents
Young, D. D., Lusic, H., Lively, M. O., Yoder, J. A., & Deiters, A. (2008) · ChemBioChem · doi:10.1002/cbic.200800627 · Cited by 95
MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease
Jin, X., Ye, Y.-F., Chen, S.-H., Yu, C., Liu, J., & Li, Y.-M. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.08.008 · Cited by 98
Plant microRNAs: new players in functional genomics
Eldem, V., Okay, S., & Ünver, T. (2013) · TURKISH JOURNAL OF AGRICULTURE AND FORESTRY · doi:10.3906/tar-1206-50 · Cited by 101
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
Martino, M. T. D., Riillo, C., Scionti, F., Grillone, K., Polerà, N., Caracciolo, D., Arbitrio, M., Tagliaferri, P., & Tassone, P. (2021) · Cancers · doi:10.3390/cancers13071587 · Cited by 102
Beyond small molecules: targeting G-quadruplex structures with oligonucleotides and their analogues
Cadoni, E., Paepe, L. D., Manicardi, A., & Madder, A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab334 · Cited by 99
“The most evident structural difference with respect to DNA oligos is the presence of a 2′–4′ methylene linkage that renders them resistant to nuclease-mediated degradation (99).”
BackgroundDevelopment of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs
Nguyen, D.-D., & Chang, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010065 · Cited by 90
“For this reason, it became a promising choice for targeting miRNAs by antisense-based gene silencing [58,62].”
BackgroundXie, T., Huang, M., Wang, Y., Wang, L., Chen, C., & Chu, X. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452525 · Cited by 90
Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.
Geretto, M., Pulliero, A., Rosano, C., Zhabayeva, D., Bersimbaev, R. I., & Izzotti, A. (2017) · PubMed · Cited by 108
Antimicrobial and Antibiofilm Coating of Dental Implants—Past and New Perspectives
Esteves, G. M., Esteves, J., Resende, M., Mendes, L., & Azevedo, A. S. (2022) · Antibiotics · doi:10.3390/antibiotics11020235 · Cited by 93
“Since this first generation of ASOs, several modifications have been made to overcome important limitations and enable clinical application such as incorporating 2′-O-methyl (2′-OMe) in the DNA backbone [44], connecting the DNA ribose ring by a methylene bridge between 2′-O and 4′-C atoms- locked nucleic acid (LNA) te…”
BackgroundDelivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals
Orava, E. W., Cicmil, N., & Gariépy, J. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.02.004 · Cited by 89
Locked nucleic acids in PCR primers increase sensitivity and performance
Ballantyne, K. N., van Oorschot, R. A. H., & Mitchell, R. J. (2008) · Genomics · doi:10.1016/j.ygeno.2007.10.016 · Cited by 87
Ellis-Connell, A. L., Iempridee, T., Xu, M., & Mertz, J. E. (2010) · Journal of Virology · doi:10.1128/jvi.00923-10 · Cited by 94
“Due to the modifications of these oligonucleotides, the binding is more energetically favored than is the binding of miRNAs to RNA and DNA molecules (82, 83).”
BackgroundmiRNA assays in the clinical laboratory: workflow, detection technologies and automation aspects
Kappel, A., & Keller, A. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0467 · Cited by 97
“As with microarrays, the specificity of the amplification reaction can be further improved by using LNA instead of DNA for the forward primer [98, 99].”
Epigenetic Deregulation of Apoptosis in Cancers
Ozyerli‐Goknar, E., & Onder, T. B. (2021) · Cancers · doi:10.3390/cancers13133210 · Cited by 102
Taylor, J. L., Lee, F. K., Yazdanpanah, G., Staropoli, J. F., Liu, M., Carulli, J. P., Sun, C., Dobrowolski, S. F., Hannon, W. H., & Vogt, R. F. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.231019 · Cited by 91
“These shorter probes are known to improve the ability to discern single-nucleotide polymorphisms (26), such as those Taylor et al.”
MicroRNAs as pharmacological targets in diabetes
Mao, Y., Mohan, R., Zhang, S., & Tang, X. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.06.005 · Cited by 91
Human salivary microRNAs in Cancer
Rapado‐González, Ó., Majem, B., Muinelo‐Romay, L., Álvarez-Castro, A., Santamaría, A., Gil‐Moreno, A., López‐López, R., & Suárez‐Cunqueiro, M. M. (2018) · Journal of Cancer · doi:10.7150/jca.21180 · Cited by 87
miRNA-Based Technologies in Cancer Therapy
Pagoni, M. N., Cava, C., Sideris, D. C., Avgeris, M., Zoumpourlis, V., Michalopoulos, I., & Drakoulis, N. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111586 · Cited by 100
Synthesis and investigation of deoxyribonucleic acid/locked nucleic acid chimeric molecular beacons
Yang, C. J., Wang, L., Wu, Y., Kim, Y., Medley, C. D., Lin, H., & Tan, W. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm358 · Cited by 84
“LNA is a conformationally restricted nucleic acid analogue, in which the ribose ring is locked into a rigid C30-endo (or Northerntype) conformation by a simple 20-O, 40-C methylene bridge (26,27) (Figure 1B).”
BackgroundPolymerase Chain Reaction and Transcription Using Locked Nucleic Acid Nucleotide Triphosphates
Veedu, R. N., Vester, B., & Wengel, J. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801389n · Cited by 84
Self-citationIdentification of axon‐enriched MicroRNAs localized to growth cones of cortical neurons
Sasaki, Y., Gross, C., Xing, L., Goshima, Y., & Bassell, G. J. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22113 · Cited by 81
“Oligonucleotides including LNA have increased thermal stability and improved discriminative power with respect to their nucleic acid targets and are therefore specifically suited for the detection of low-abundant miRNAs (Vester and Wengel, 2004).”
BackgroundMicroRNAs in cancer treatment and prognosis.
Schoof, C. R. G., Botelho, E. L. D. S., Izzotti, A., & Vasques, L. R. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 93
Development of MicroRNAs as Potential Therapeutics against Cancer
Abd-Aziz, N., Kamaruzman, N. I., & Poh, C. L. (2020) · Journal of Oncology · doi:10.1155/2020/8029721 · Cited by 97
“AMOs are single-stranded, chemically modified antisense oligonucleotides that are about 17–22 nucleotides and were designed to be complementary to a miRNA of interest [65].”
BackgroundClinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases
Holm, A., Hansen, S. N., Klitgaard, H., & Kauppinen, S. (2022) · RNA Biology · doi:10.1080/15476286.2022.2066334 · Cited by 99
“nucleic acid (LNA) modification, in which the ribose sugar is locked in a C3’-endo conformation by introduction of a 2’-O,4’C methylene bridge[13].”
BackgroundLocked Nucleic Acid: High-Affinity Targeting of Complementary RNA for RNomics
Kauppinen, S., Vester, B., & Wengel, J. (2006) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-27262-3_21 · Cited by 83
“…descriptions on the overall properties and biotechnological applications of LNA, including DNA diagnostics and double-stranded (ds)DNA targeting by triple helix formation, the reader is referred to recent reviews on LNA (Petersen and Wengel 2003; Jepsen and Wengel 2004; Vester and Wengel 2004).”
BackgroundSelf-citationSelecting, Acquiring, and Using Small Molecule Libraries for High‐Throughput Screening
Dandapani, S., Rossé, G., Southall, N. T., Salvino, J. M., & Thomas, C. J. (2012) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch110252 · Cited by 95
“These include peptoids, peptide nucleic acids (PNA), and locked nucleic acids (LNA; Vester and Wengel, 2004; Shakeel et al., 2006; Yoo and Kirshenbaum, 2008).”
BackgroundNewborn screening for spinal muscular atrophy: Anticipating an imminent need
Phan, H. C., Taylor, J. L., Hannon, H., & Howell, R. R. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.03.006 · Cited by 82
From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies
Adachi, H., Hengesbach, M., Yu, Y., & Morais, P. (2021) · Biomedicines · doi:10.3390/biomedicines9050550 · Cited by 92
“The LNA modification, often used in situations where there is a need to increase the binding affinity to the target RNA, can favor an A-form duplex conformation with the target, thus increasing the melting temperature [35].”
BackgroundTargeting DNA with triplex-forming oligonucleotides to modify gene sequence
Simon, P., Cannata, F., Concordet, J., & Giovannangeli, C. (2008) · Biochimie · doi:10.1016/j.biochi.2008.04.004 · Cited by 83
microRNAs in Adult Rodent Liver Are Refractory to Dioxin Treatment
Moffat, I. D., Boutros, P. C., Celius, T., Lindén, J., Pohjanvirta, R., & Okey, A. B. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm189 · Cited by 86
“The capture probes are melting temperature–normalized locked nucleic acid (LNA)–enhanced oligonucleotides (Vester and Wengel, 2004) that all hybridize optimally under a common set of conditions.”
BackgroundMethodInfluentialWang, F., Zhang, B., Zhou, L. M., Shi, Y., Li, Z., Xia, Y., & Tian, J. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b02662 · Cited by 80
Role of non‐coding RNA s in pancreatic beta‐cell development and physiology
Eliasson, L., & Esguerra, J. L. S. (2014) · Acta Physiologica · doi:10.1111/apha.12285 · Cited by 82
“LNA-based oligos display structural stability and thermodynamic properties favourable to hybridization due to the ethylene bridge modification in the 20 and 30 carbon atoms of the sugar backbone of nucleotides (Vester & Wengel 2004).”
BackgroundMolekulartechnische DNA‐Modifizierung: Molecular Beacons
Wang, K., Tang, Z., Yang, C. J., Kim, Y., Fang, X., Li, W., Wu, Y., Medley, C. D., Cao, Z. C., Li, J., et al. (2008) · Angewandte Chemie · doi:10.1002/ange.200800370 · Cited by 78
Non-coding RNAs: Identification of Cancer-Associated microRNAs by Gene Profiling
Ferdin, J., Kunej, T., & Calin, G. A. (2010) · Technology in Cancer Research & Treatment · doi:10.1177/153303461000900202 · Cited by 80
Recent Progress in Chemically Modified siRNAs
Gaglione, M., & Messere, A. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791384036 · Cited by 76
“Three generations of chemically modified ASOs have been developed to enhance nuclease resistance, prolong tissue half-life, reduce off-target effects and increase affinity and potency [7, 17-24].”
BackgroundComparative Analysis of the MIR319a MicroRNA Locus in Arabidopsis and Related Brassicaceae
Warthmann, N., Das, S., Lanz, C., & Weigel, D. (2008) · Molecular Biology and Evolution · doi:10.1093/molbev/msn029 · Cited by 75
Lipid–oligonucleotide conjugates for bioapplications
Li, X., Feng, K., Li, L., Yang, L., Pan, X., Yazd, H. S., Cui, C., Li, J., Moroz, L. L., Sun, Y., et al. (2020) · National Science Review · doi:10.1093/nsr/nwaa161 · Cited by 78
“However, modifications onONs such as peptide nucleic acids (PNAs) and locked nucleic acids (LNAs) have rendered significant nuclease resistance due to their unnatural entities-mediated low recognition fromnuclease,with an increasedhalf-life from hours to days [44,45].”
BackgroundRecognition of RNA duplexes by chemically modified triplex-forming oligonucleotides
Zhou, Y., Kierzek, E., Loo, Z. P., Antonio, M., Yau, Y. H., Chuah, Y. W., Shochat, S. G., Kierzek, R., & Chen, G. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt352 · Cited by 75
Antisense Oligonucleotide-Based Therapies for Diseases Caused by pre-mRNA Processing Defects
Rigo, F., Seth, P. P., & Bennett, C. F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_9 · Cited by 80
Kumar, M., Guo, Y., & Zhang, P. (2008) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2008.08.023 · Cited by 73
Otoukesh, B., Abbasi, M., Gorgani, H.-O.-L., Farahini, H., Moghtadaei, M., Boddouhi, B., Kaghazian, P., Hosseinzadeh, S., & Alaee, A. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01342-4 · Cited by 77
Stabilization of Expanded (CTG)•(CAG) Repeats by Antisense Oligonucleotides
Nakamori, M., Gourdon, G., & Thornton, C. A. (2011) · Molecular Therapy · doi:10.1038/mt.2011.191 · Cited by 72
Synthesis and properties of 2′-O,4′-C-methyleneoxymethylene bridged nucleic acid
Hari, Y., Obika, S., Ohnishi, R., Eguchi, K., Osaki, T., Ohishi, H., & Imanishi, T. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.09.020 · Cited by 72
MicroRNA Silencing in Primates: Towards Development of Novel Therapeutics
Petri, A., Lindow, M., & Kauppinen, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2749 · Cited by 74
“In addition, LNA oligonucleotides display high stability, low toxicity, and exhibit good aqueous solubility and potent antisense activity in vivo ( 14 ).”
BackgroundInfluentialDesign and evaluation of locked nucleic acid-based splice-switching oligonucleotidesin vitro
Shimo, T., Tachibana, K., Saito, K., Yoshida, T., Tomita, E., Waki, R., Yamamoto, T., Doi, T., Inoué, T., Kawakami, J., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku512 · Cited by 75
“LNA contains a methylene bridge connecting the 2’-O with the 4’-C position in the furanose ring, which enables it to form a strictly N-type conformation that offers high binding affinity against complementary RNA (14,15,16).”
BackgroundKotik, M. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2009.08.013 · Cited by 70
Molecular therapy in the microRNA era
Würdinger, T., & Costa, F. F. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500429 · Cited by 75
Structures of telomerase at several steps of telomere repeat synthesis
He, Y., Wang, Y., Liu, B., Helmling, C., Sušac, L., Cheng, R., Zhou, Z. H., & Feigon, J. F. (2021) · Nature · doi:10.1038/s41586-021-03529-9 · Cited by 79
Hansen, M. E., Bentin, T., & Nielsen, P. E. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp437 · Cited by 75
“Several pentadecameric PNAs in the present study show low nanomolar (e.g. PNA3051) or sub-nanomolar (PNA3049 and PNA3050) EC50 values for triplex formation at pH 7.2, which rivals or indeed supersedes the dsDNA triplex affinity of reported acridine conjugated hexadecameric LNA oligomers.”
BackgroundInfluentialSnellenberg, S., Strooper, L. M. A. D., Hesselink, A. T., Meijer, C. J. L. M., Snijders, P. J. F., Heideman, D. A. M., & Steenbergen, R. D. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-551 · Cited by 69
“The analytical performance of the multiplex qMSP could potentially be further improved by the incorporation of Locked Nucleic Acids (LNAs) in primers and/or hydrolysis probes [28], as has been described for singleplex MGMT [29] and CADM1 [30] qMSPs.”
MethodPotential of microRNAs for cancer diagnostics, prognostication and therapy
Garzon, R., & Marcucci, G. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328358522c · Cited by 76
“More recently, the locked nucleic acid (LNA) modification was introduced in antisense miRNA oligonucleotides [33].”
BackgroundThe Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
Adinew, G. M., Taka, E., Mendonca, P., Messeha, S. S., & Soliman, K. F. A. (2021) · Nutrients · doi:10.3390/nu13041212 · Cited by 72
“This study suggests that the mir-655/rxx1 and mir-136/RASAL2/MET axis acts as a suppressor of TNBC metastasis [114,183].”
BackgroundZhang, Y., Qu, Z., Kim, S., Shi, V, Liao, B., Kraft, P., Bandaru, R., Wu, Y., Greenberger, L. M., & Horak, I. D. (2011) · Gene Therapy · doi:10.1038/gt.2010.133 · Cited by 68
Enzymatic Incorporation of LNA Nucleotides into DNA Strands
Veedu, R. N., Vester, B., & Wengel, J. (2007) · ChemBioChem · doi:10.1002/cbic.200600501 · Cited by 67
Self-citationPosition-dependent effects of locked nucleic acid (LNA) on DNA sequencing and PCR primers
Levin, J. D., Fiala, D., Samala, M. F., Kahn, J. D., & Peterson, R. J. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl756 · Cited by 67
“LNA provides the largest known increase in thermal stability of any modified DNA duplex (4), because it reduces the unfavorable entropy of duplex formation and may improve base stacking.”
BackgroundNon-natural nucleic acids for synthetic biology
Appella, D. H. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.09.030 · Cited by 74
Mitsuoka, Y., Kodama, T., Ohnishi, R., Hari, Y., Imanishi, T., & Obika, S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1062 · Cited by 65
“2-N-Isobutyryl-2’-O,4’-C-(methylenoxymethylene) guanosine (22)”
Molecular beacons in biomedical detection and clinical diagnosis.
Kim, Y., Sohn, D., & Tan, W. (2008) · PubMed · Cited by 75
Dynamic microRNA-101a and Fosab expression controls zebrafish heart regeneration
Beauchemin, M., Smith, A., & Yin, V. P. (2015) · Development · doi:10.1242/dev.126649 · Cited by 68
FASTmiR: an RNA-based sensor for in vitro quantification and live-cell localization of small RNAs
Huang, K., Doyle, F., Wurz, Z. E., Tenenbaum, S. A., Hammond, R. K., Caplan, J. L., & Meyers, B. C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx504 · Cited by 66
“To check whether FASTmiR171 was able to detect changes and was specific to miR171 in a background of total RNA, the reverse complement of miR171 (designated as miR171rc, with the sequence GATATTGGCGCGGCTCAATCA [MW = 5613.6 g/mole], underlined nucleotides are LNAs) was added to total RNA from Arabidopsis inflorescences…”
BackgroundMethodInfluentialAnwar, S., Mir, F., & Yokota, T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041130 · Cited by 71
MicroRNAs in common diseases and potential therapeutic applications
Tsai, L. M., & Yu, D. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05269.x · Cited by 68
“Many chemical modifications have been designed to enhance miRNA inhibition, of which the method of locked nucleic acids (LNA) has exhibited unprecedented thermal stability with miRNA, high self-stability, low toxicity and good aqueous solubility in vivo.(65) The LNA is a bicyclic high-affinity”
BackgroundTemplated Ligand Environments for the Selective Incorporation of Different Metals into DNA
Yang, H. S., Rys, A. Z., McLaughlin, C. K., & Sleiman, H. F. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200904186 · Cited by 61
Aptamers as a model for functional evaluation of LNA and 2′-amino LNA
Hernández, F. J., Kalra, N., Wengel, J., & Vester, B. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.039 · Cited by 60
Self-citationMelanocortin 4 receptor distribution in the human hypothalamus
Siljee, J. E., Unmehopa, U. A., Kalsbeek, A., Swaab, D. F., Fliers, E., & Alkemade, A. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0750 · Cited by 60
Antisense applications for biological control
Pan, W.-H., & Clawson, G. A. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20790 · Cited by 62
“Others include 20-O, 40C-methylene bridge nucleic acid (BNA/LNA, [Vester and Wengel, 2004]), 20-O, 40-C-ethylene bridge nucleic acid (ENA, [Takagi et al.”
BackgroundAptamers as Drug Delivery Vehicles
Kruspe, S., Mittelberger, F., Szameit, K., & Hahn, U. (2014) · ChemMedChem · doi:10.1002/cmdc.201402163 · Cited by 60
Su, Y., Xiong, J., Hu, J., Wei, X., Zhang, X., & Rao, L. (2016) · Oncotarget · doi:10.18632/oncotarget.11722 · Cited by 62
“Locked nucleic acid (LNA)-modified oligonucleotide probes (Exiqon) were used for ISH [44].”
InfluentialVeedu, R. N., & Wengel, J. (2009) · Molecular BioSystems · doi:10.1039/b905513b · Cited by 60
Self-citationTherapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
Borsi, E., Terragna, C., Brioli, A., Tacchetti, P., Martello, M., & Cavo, M. (2014) · Translational research · doi:10.1016/j.trsl.2014.12.001 · Cited by 67
Anti–miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice
Zhou, Y., Abraham, S., André, P., Edelstein, L. C., Shaw, C. A., Dangelmaier, C., Tsygankov, A. Y., Kunapuli, S. P., Bray, P. F., & McKenzie, S. E. (2015) · Blood · doi:10.1182/blood-2015-02-631135 · Cited by 68
“LNAs are physiologically stable, resistant to nucleases, have low cytotoxicity, and have robust antisense efficacy and specificity in vivo.(25) In cardiovascular diseases, miRNA inhibition has been used to regulate atherosclerosis, cardiac function, and vascular biology in animalmodels.”
BackgroundMethodZhong, X., Coukos, G., & Zhang, L. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-427-8_21 · Cited by 69
Recent Advances in the Molecular Beacon Technology for Live-Cell Single-Molecule Imaging
Mao, S., Ying, Y., Wu, R., & Chen, A. K. (2020) · iScience · doi:10.1016/j.isci.2020.101801 · Cited by 68
RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases
Germain, N. D., Chung, W. K., & Sarmiere, P. D. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101148 · Cited by 65
Suparpprom, C., & Vilaivan, T. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00017b · Cited by 67
Hagey, R. J., Elazar, M., Pham, E. A., Tian, S., Ben‐Avi, L., Bernardin-Souibgui, C., Yee, M. F., Moreira, F. R., Rabinovitch, M. V., Meganck, R. M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01908-x · Cited by 62
“Nine antisense oligonucleotides (ASOs) with modified LNA bases 23 were designed against PSL2 to disrupt various regions of the overall RNA secondary structure (Fig.”
A Sensitive Alternative for MicroRNA In Situ Hybridizations Using Probes of 2′-O-Methyl RNA + LNA
Søe, M. J., Møller, T., Dufva, M., & Holmstrøm, K. (2011) · Journal of Histochemistry and Cytochemistry · doi:10.1369/0022155411409411 · Cited by 63
“LNAs are RNA nucleotides containing a methylene bridge between the 2′-oxygen and 4′-carbon, locking the ribose in a C3′endo conformation (Koshkin et al. 1998; Vester and Wengel 2004).”
BackgroundRahman, S. M. A., Seki, S., Obika, S., Haitani, S., Miyashita, K., & Imanishi, T. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604857 · Cited by 57
Studies on DNA binding to metal complexes of Sal2trien
Zhou, C.-Y., Xi, X.-L., & Yang, P. (2007) · Biochemistry (Moscow) · doi:10.1134/s000629790701004x · Cited by 56
microRNAs as pharmacological targets in cancer
Soriano, A., Jubierre, L., Almazán-Moga, A., Molist, C., Roma, J. M., de Toledo, J. S., Gallego, S., & Segura, M. F. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.03.006 · Cited by 62
RETRACTED: miRNA-302b Suppresses Human Hepatocellular Carcinoma by Targeting AKT2
Wang, L., Yao, J., Zhang, X., Guo, B., Le, X., Cubberly, M. R., Li, Z., Nan, K., Song, T., & Huang, C. Y. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0411 · Cited by 58
“Further systemic administration of miR302b delivered by cholesterol conjugated 20-O-methyl-modified oligonucleotides, lentivirus vector (42), AAV vectors (43), or locked nucleic acid-modified oligonucleotides (44) could be performed for further determination of the anticancer potential of hepatocellular carcinoma.”
BackgroundRetractedNon-Coding RNAs in Thyroid Cancer
Zhang, R., Hardin, H. A., Chen, J., Guo, Z., & Lloyd, R. V. (2016) · Endocrine Pathology · doi:10.1007/s12022-016-9417-8 · Cited by 56
Developments in in situ hybridisation
Cassidy, A., & Jones, J. L. (2014) · Methods · doi:10.1016/j.ymeth.2014.04.006 · Cited by 63
Hu, J., Matsui, M., & Corey, D. R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04975.x · Cited by 61
Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases
Fattal, E., & Fay, F. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.019 · Cited by 60
Locked nucleic acid (LNA): A modern approach to cancer diagnosis and treatment
Kamali, M. J., Salehi, M., Fatemi, S., Moradi, F., Khoshghiafeh, A., & Ahmadifard, M. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113442 · Cited by 58
Beckmann, B. M., Hoch, P. G., Marz, M., Willkomm, D. K., Salas, M., & Hartmann, R. K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.23 · Cited by 58
“For this purpose, we pre-annealed an isosequential all-LNA 8-mer (LNA, locked nucleic acid (Vester and Wengel, 2004; Grünweller and Hartmann, 2007); all-LNA, LNA analogues”
Iribe, H., Miyamoto, K., Takahashi, T., Kobayashi, Y., Leo, J., Aida, M., & Ui‐Tei, K. (2017) · ACS Omega · doi:10.1021/acsomega.7b00291 · Cited by 59
Glioma angiogenesis: Towards novel RNA therapeutics
Würdinger, T., & Tannous, B. A. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.2.7910 · Cited by 57
The crystal structure of an ‘All Locked’ nucleic acid duplex
Eichert, A., Behling, K., Betzel, C., Erdmann, V., Fürste, J., & Förster, C. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq505 · Cited by 48
“Structural investigations using 20-O-40Cmethylene-b-D-ribofuranose LNA–RNA mix-mers hybridized to RNA showed that introduction of single LNA nucleotides in double strands maintains the RNA A-type nucleic acid conformation, whereas the use of aL-20-O-40C ribofuranose LNA–DNA mix-mers hybridized to DNA helices results i…”
BackgroundTran, T. A., Childs‐Disney, J. L., Liu, B., Guan, L., Rzuczek, S. G., & Disney, M. D. (2014) · ACS Chemical Biology · doi:10.1021/cb400875u · Cited by 57
MicroRNA Theranostics in Prostate Cancer Precision Medicine
Matin, F., Jeet, V., Clements, J. A., Yousef, G. M., & Batra, J. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.242800 · Cited by 62
Meyer, C., Garzia, A., & Tuschl, T. (2016) · Methods · doi:10.1016/j.ymeth.2016.09.010 · Cited by 53
“ISH is a technique in which labeled single-stranded antisense RNA, DNA, or locked nucleic acid (LNA) probes are hybridized to immobilized RNA or DNA molecules in paraformaldehyde fixed cells or tissues [4,5].”
BackgroundCortez, M. A., Ivan, C., Zhou, P., Wu, X., Ivan, M., & Calin, G. A. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380888-2.00004-2 · Cited by 59
Piao, X., Wang, H., Binzel, D. W., & Guo, P. (2017) · RNA · doi:10.1261/rna.063057.117 · Cited by 58
“Extensive studies have been performed on the effects of chemical modifications on the thermodynamic stability (De Mesmaeker et al. 1995; Vester and Wengel 2004; Karkare and Bhatnagar 2006) and chemical stability (Kawasaki et al. 1993; Heidenreich et al. 1994; Allerson et al. 2005) of duplex and…”
Background
Metadata
- Authors
- Vester, B., & Wengel, J.
- Affiliations
- University of Southern Denmark (DK)
- Corresponding author
- Vester, Birte
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2004-10-01
- Volume
- 43
- Issue
- 42
- Pages
- 13233-13241
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2139273728
- Cited by
- 727
- References
- 57
- Citations by year
- 2026: 19 · 2025: 34 · 2024: 23 · 2023: 28 · 2022: 38 · 2021: 32 · 2020: 26 · 2019: 27 · 2018: 32 · 2017: 24 · 2016: 40 · 2015: 34 · 2014: 45 · 2013: 35 · 2012: 54
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Keywords
- locked nucleic acid, LNA oligonucleotides, nucleic acid analogs, hybridization affinity, gene silencing, nucleic acid diagnostics, RNA mimics
- MeSH terms
- Endoribonucleases, Hydrolysis, Nucleic Acid Conformation, Nucleotides, Oligonucleotides, Ribose, Oligonucleotides, Antisense, RNA, Complementary, DNA, Complementary, Molecular Mimicry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.